Investors in Jiangxi Fushine Pharmaceutical may hope for gro...

Investors in Jiangxi Fushine Pharmaceutical may hope for growth and profits as current stock performance disappoints. Long-term shareholders saw a 3% annual return over 5 years. The recent sell-off could signal an investment opportunity, if company fundamentals show long-term growth.